Effect of epitope position on neutralization by anti-human immunodeficiency virus monoclonal antibody 2F5

被引:18
作者
Ou, W [1 ]
Lu, N [1 ]
Yu, SS [1 ]
Silver, J [1 ]
机构
[1] NIAID, Mol Microbiol Lab, NIH, Bethesda, MD 20892 USA
关键词
D O I
10.1128/JVI.80.5.2539-2547.2006
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The membrane-proximal region of the human immunodeficiency virus type 1 (HIV-1) transmembrane protein (TM) is critical for envelope (Env)-mediated membrane fusion and contains the target for broadly reactive neutralizing antibody 2F5. It has been proposed that 2F5 neutralization might involve interaction of its long, hydrophobic, complementarity-determining region (CDR) 113, with adjacent viral membrane. Using Moloney murine leukemia virus (MLV) as a tool, we examined the effect of epitope position on 2F5 neutralization. When the 2175 epitope was inserted in the proline-rich region of MLV Env surface protein (SU), 2F5 blocked cell fusion and virus infection, whereas MLV with a hemagglutinin (HA) epitope at the same position was not neutralized by anti-HA, even though the antibodies bound their respective Envs on the surface of infected cells and viruses equally well. When the 2175 epitope was inserted in the MLV Env TM at a position comparable to its natural position in HIV-1 TM, 2F5 antibody blocked Env-mediated cell fusion. Epitope position had subtle effects on neutralization by 2F5: the antibody concentration for 50% inhibition of cell fusion was more than 10-fold lower when the 2175 epitope was in SU than in TM, and inhibition was less complete at high concentrations of antibody; we discuss possible explanations for these effects of epitope position. Since membrane proximity was not required for neutralization by 2F5 antibody, we speculate that the CDR H3 of 2F5 contributes to neutralization by destabilizing an adjacent protein rather than by inserting into an adjacent membrane.
引用
收藏
页码:2539 / 2547
页数:9
相关论文
共 64 条
  • [1] A PUTATIVE MURINE ECOTROPIC RETROVIRUS RECEPTOR GENE ENCODES A MULTIPLE MEMBRANE-SPANNING PROTEIN AND CONFERS SUSCEPTIBILITY TO VIRUS-INFECTION
    ALBRITTON, LM
    TSENG, L
    SCADDEN, D
    CUNNINGHAM, JM
    [J]. CELL, 1989, 57 (04) : 659 - 666
  • [2] Structural analysis of the epitope of the Anti-HIV antibody 2F5 sheds light into its mechanism of neutralization and HIV fusion
    Barbato, G
    Bianchi, E
    Ingallinella, P
    Hurni, WH
    Miller, MD
    Cilibertol, G
    Cortese, R
    Bazzo, R
    Shiver, JW
    Pessi, A
    [J]. JOURNAL OF MOLECULAR BIOLOGY, 2003, 330 (05) : 1101 - 1115
  • [3] GENERATION OF HUMAN MONOCLONAL-ANTIBODIES AGAINST HIV-1 PROTEINS - ELECTROFUSION AND EPSTEIN-BARR-VIRUS TRANSFORMATION FOR PERIPHERAL-BLOOD LYMPHOCYTE IMMORTALIZATION
    BUCHACHER, A
    PREDL, R
    STRUTZENBERGER, K
    STEINFELLNER, W
    TRKOLA, A
    PURTSCHER, M
    GRUBER, G
    TAUER, C
    STEINDL, F
    JUNGBAUER, A
    KATINGER, H
    [J]. AIDS RESEARCH AND HUMAN RETROVIRUSES, 1994, 10 (04) : 359 - 369
  • [4] Distinct mechanisms of neutralization by monoclonal antibodies specific for sites in the N-terminal or C-terminal domain of murine leukemia virus SU
    Burkhart, MD
    Kayman, SC
    He, YX
    Pinter, A
    [J]. JOURNAL OF VIROLOGY, 2003, 77 (07) : 3993 - 4003
  • [5] EFFICIENT NEUTRALIZATION OF PRIMARY ISOLATES OF HIV-1 BY A RECOMBINANT HUMAN MONOCLONAL-ANTIBODY
    BURTON, DR
    PYATI, J
    KODURI, R
    SHARP, SJ
    THORNTON, GB
    PARREN, PWHI
    SAWYER, LSW
    HENDRY, RM
    DUNLOP, N
    NARA, PL
    LAMACCHIA, M
    GARRATTY, E
    STIEHM, ER
    BRYSON, YJ
    CAO, YZ
    MOORE, JP
    HO, DD
    BARBAS, CF
    [J]. SCIENCE, 1994, 266 (5187) : 1024 - 1027
  • [6] Burton DR, 2001, CURR TOP MICROBIOL, V260, P109
  • [7] Broadly neutralizing anti-HIV antibody 4E10 recognizes a helical conformation of a highly conserved fusion-associated motif in gp41
    Cardoso, RMF
    Zwick, MB
    Stanfield, RL
    Kunert, R
    Binley, JM
    Katinger, H
    Burton, DR
    Wilson, IA
    [J]. IMMUNITY, 2005, 22 (02) : 163 - 173
  • [8] Core structure of gp41 from the HIV envelope glycoprotein
    Chan, DC
    Fass, D
    Berger, JM
    Kim, PS
    [J]. CELL, 1997, 89 (02) : 263 - 273
  • [9] Envelope glycoprotein incorporation, not shedding of surface envelope glycoprotein (gp120/SU), is the primary determinant of SU content of purified human immunodeficiency virus type 1 and simian immunodeficiency virus
    Chertova, E
    Bess, JW
    Crise, BJ
    Sowder, RC
    Schaden, TM
    Hilburn, JM
    Hoxie, JA
    Benveniste, RE
    Lifson, JD
    Henderson, LE
    Arthur, LO
    [J]. JOURNAL OF VIROLOGY, 2002, 76 (11) : 5315 - 5325
  • [10] Antigenicity and immunogenicity of the HIV-1 gp41 epitope ELDKWA inserted into permissive sites of the MalE protein
    Coëffier, E
    Clément, JM
    Cussac, V
    Khodaei-Boorane, N
    Jehanno, M
    Rojas, M
    Dridi, A
    Latour, M
    El Habib, R
    Barré-Sinoussi, F
    Hofnung, M
    Leclerc, C
    [J]. VACCINE, 2000, 19 (7-8) : 684 - 693